Evidence map›Paper›PMID 35701754›Full record

ArticleMolecular brain2022

Impaired mitochondrial accumulation and Lewy pathology in neuron-specific FBXO7-deficient mice.

Sachiko Noda, Shigeto Sato, Takahiro Fukuda, Shinichi Ueno, Norihiro Tada, Nobutaka Hattori

Open access · goldAbstract read
In one paragraph

Article in Molecular brain, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sachiko NodaDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan.
Shigeto SatoDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan.
Takahiro FukudaDivision of Neuropathology, Department of Neuropathology, The Jikei University School of Medicine, Tokyo, 105-8461, Japan.
Shinichi UenoDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan.
Norihiro TadaAtopy Research Center, Juntendo University School of Medicine, Tokyo, 113-8421, Japan.
Nobutaka HattoriDepartment of Neurology, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan. nhattori@juntendo.ac.jp.ORCID 0000-0002-2034-2556
Juntendo University · JPJikei University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease, the second most common neurodegenerative disorder, is characterized by the loss of nigrostriatal dopamine neurons. FBXO7 (F-box protein only 7) (PARK15) mutations cause early-onset Parkinson's disease. FBXO7 is a subunit of the SCF (SKP1/cullin-1/F-box protein) E3 ubiquitin ligase complex, but its neuronal relevance and function have not been elucidated. To determine its function in neurons, we generated neuronal cell-specific FBXO7 conditional knockout mice (FBXO7

Indexed as

F-Box ProteinsLewy BodiesMitochondriaParkinson DiseaseAnimalsDopaminergic NeuronsMiceMice, KnockoutNestinF-Box ProteinsFBXO7 protein, mouseNestinDopaminergic neuronFBXO7Mitochondriap62Parkinson’s diseaseSynuclein

Identifiers

PMID35701754
PMCPMC9199167
OpenAlexW4282924817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.